Cash Flows Statements (USD $) In Millions, unless otherwise specified	12 Months Ended
	Jun. 30, 2012		Jun. 30, 2011	Jun. 30, 2010
Operations
Net income	$ 16,978	[1]	$ 23,150	$ 18,760
Adjustments to reconcile net income to net cash from operations:
Goodwill impairment	6,193		0	0
Depreciation, amortization, and other	2,967		2,766	2,673
Stock-based compensation expense	2,244		2,166	1,891
Net recognized gains on investments and derivatives	(200)		(362)	(208)
Excess tax benefits from stock-based compensation	(93)		(17)	(45)
Deferred income taxes	954		2	(220)
Deferral of unearned revenue	36,104		31,227	29,374
Recognition of unearned revenue	(33,347)		(28,935)	(28,813)
Changes in operating assets and liabilities:
Accounts receivable	(1,156)		(1,451)	(2,238)
Inventories	184		(561)	(44)
Other current assets	493		(1,259)	464
Other long-term assets	(248)		62	(223)
Accounts payable	(31)		58	844
Other current liabilities	410		(1,146)	451
Other long-term liabilities	174		1,294	1,407
Net cash from operations	31,626		26,994	24,073
Financing
Short-term debt repayments, maturities of 90 days or less, net	0		(186)	(991)
Proceeds from issuance of debt, maturities longer than 90 days	0		6,960	4,167
Repayments of debt, maturities longer than 90 days	0		(814)	(2,986)
Common stock issued	1,913		2,422	2,311
Common stock repurchased	(5,029)		(11,555)	(11,269)
Common stock cash dividends paid	(6,385)		(5,180)	(4,578)
Excess tax benefits from stock-based compensation	93		17	45
Other	0		(40)	10
Net cash used in financing	(9,408)		(8,376)	(13,291)
Investing
Additions to property and equipment	(2,305)		(2,355)	(1,977)
Acquisition of companies, net of cash acquired, and purchases of intangible and other assets	(10,112)		(71)	(245)
Purchases of investments	(57,250)		(35,993)	(30,168)
Maturities of investments	15,575		6,897	7,453
Sales of investments	29,700		15,880	15,125
Securities lending payable	(394)		1,026	(1,502)
Net cash used in investing	(24,786)		(14,616)	(11,314)
Effect of exchange rates on cash and cash equivalents	(104)		103	(39)
Net change in cash and cash equivalents	(2,672)		4,105	(571)
Cash and cash equivalents, beginning of period	9,610		5,505	6,076
Cash and cash equivalents, end of period	$ 6,938		$ 9,610	$ 5,505

[1] Includes a goodwill impairment charge related to our OSD business segment which decreased net income by $6.2 billion and diluted earnings per share by $0.73.